DiscoverStraight From The Cutter's Mouth: A Retina PodcastEpisode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)
Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Update: 2025-04-02
Share

Description

Drs. Akshay Thomas and Priya Vakharia join to preview the April 2025 edition of Retinal Physician, focusing on current and future therapies for neovascular AMD.

Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech, Regeneron, and Eyepoint. Dr. Vakharia has consulted for Regeneron, Ocular Therapeutix, and Eyepoint.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Jayanth Sridhar